Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 1916
TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347265(US10202411, Compound 327)
Affinity DataIC50: 250nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein [S283T](HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347265(US10202411, Compound 327)
Affinity DataIC50: 250nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein [S283T](HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347266(US10202411, Compound 330)
Affinity DataIC50: 250nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein [S283T](HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347259(US10202411, Compound 302)
Affinity DataIC50: 250nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347260(US10202411, Compound 305)
Affinity DataIC50: 250nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347259(US10202411, Compound 302)
Affinity DataIC50: 250nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347262(US10202411, Compound 308)
Affinity DataIC50: 250nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein [S283T](HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347262(US10202411, Compound 308)
Affinity DataIC50: 250nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein [S283T](HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347260(US10202411, Compound 305)
Affinity DataIC50: 250nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347268(US10202411, Compound 332)
Affinity DataIC50: 625nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347266(US10202411, Compound 330)
Affinity DataIC50: 625nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347261(US10202411, Compound 307)
Affinity DataIC50: 625nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347263(US10202411, Compound 325)
Affinity DataIC50: 5.50E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347264(US10202411, Compound 326)
Affinity DataIC50: 5.50E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347272(US10202411, Compound 402)
Affinity DataIC50: 5.50E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347258(US10202411, Compound 301)
Affinity DataIC50: 5.50E+3nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347267(US10202411, Compound 331)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347271(US10202411, Compound 401)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347269(US10202411, Compound 334)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Idenix Pharmaceuticals

US Patent
LigandPNGBDBM347270(US10202411, Compound 335)
Affinity DataIC50: 1.00E+4nMAssay Description:Test compounds in the form of nucleoside triphosphates were examined for inhibitory activity against purified HCV polymerase in a standard assay. Bac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/2/2019
Entry Details
US Patent